drugset / Trial / NCT01643889

A Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Healthy Volunteers

NCT01643889

Phase 1 Completed 44 enrolled Janssen Research & Development, LLC
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to assess the effects of single and multiple doses of domperidone on the QTc interval duration in healthy adult volunteers at domperidone doses of 10 mg four times a day (q.i.d.) and 20 mg q.i.d.

Timeline

Start
2012-07
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Domperidone Unknown 10 mg Oral
Subject Domperidone Unknown 20 mg Oral
Subject Moxifloxacin Small molecule 400 mg Oral

Indications

No indication recorded.